Health Care & Life Sciences » Medical Equipment & Supplies | Navidea Biopharmaceuticals Inc.

Navidea Biopharmaceuticals Inc.

Navidea Biopharmaceuticals Inc.
Stock Exchange NYSE
EPS
$1.33
Market Cap
$10.8 M
Shares Outstanding
18.06 M
Public Float
152.4 M
Navidea Biopharmaceuticals Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
163.62 M
Public Float
156.27 M

Profile

Address
4995 Bradenton Avenue
Dublin Ohio 43017
United States
Employees -
Website http://www.navidea.com
Updated 07/08/2019
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It is developing multiple precision-targeted products based on their manocept platform to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care. The company operates through the following segments: Diagnostics, Therapeutics, and Corporate.

Financials

View All

Jed Andrew Latkin
CEO, COO, CFO, Secretary, Director & Treasurer
Claudine E. Bruck
Director